AAAAAA
Results:
1-15
|
Results: 15
Authors:
WATANABE N
YOKOYAMA K
KINUYA S
SHUKE N
SHIMIZU M
FUTATSUYA R
MICHIGISHI T
TONAMI N
SETO H
GOODWIN DA
Citation: N. Watanabe et al., RADIOTOXICITY AFTER I-131 THERAPY FOR THYROID-CANCER USING THE MICRONUCLEUS ASSAY, The Journal of nuclear medicine, 39(3), 1998, pp. 436-440
Authors:
GOODWIN DA
MEARES CF
OSEN M
Citation: Da. Goodwin et al., BIOLOGICAL PROPERTIES OF BIOTIN-CHELATE CONJUGATES FOR PRETARGETED DIAGNOSIS AND THERAPY WITH THE AVIDIN BIOTIN SYSTEM/, The Journal of nuclear medicine, 39(10), 1998, pp. 1813-1818
Authors:
MORLEY TJ
EVANS GO
GOODWIN DA
READ NG
HODGSON ST
HAWKSWORTH GM
Citation: Tj. Morley et al., STRUCTURE-ACTIVITY RELATIONSHIP FOR 2 LIPOXYGENASE INHIBITORS AND THEIR POTENTIAL FOR INDUCING NEPHROTIC SYNDROME, Toxicology and applied pharmacology, 146(2), 1997, pp. 299-308
Authors:
GOODWIN DA
MEARES CF
Citation: Da. Goodwin et Cf. Meares, PRETARGETING - GENERAL-PRINCIPLES - OCTOBER 10-12 1996, Cancer, 80(12), 1997, pp. 2675-2680
Authors:
RENN O
GOODWIN DA
STUDER M
MORAN JK
JACQUES V
MEARES CF
Citation: O. Renn et al., NEW APPROACHES TO DELIVERING METAL-LABELED ANTIBODIES TO TUMORS - SYNTHESIS AND CHARACTERIZATION OF NEW BIOTINYL CHELATE CONJUGATES FOR PRE-TARGETED DIAGNOSIS AND THERAPY, Journal of controlled release, 39(2-3), 1996, pp. 239-249
Authors:
CALLAHAN RJ
CHILTON HM
GOODWIN DA
HNATOWICH DJ
PONTO JA
SWANSON DP
ROYAL HJ
Citation: Rj. Callahan et al., PROCEDURE GUIDELINE FOR IMAGING WITH RADIOPHARMACEUTICALS - 1.0, The Journal of nuclear medicine, 37(12), 1996, pp. 2092-2094
Authors:
READ NG
ASTBURY PJ
EVANS GO
GOODWIN DA
ROWLANDS A
Citation: Ng. Read et al., NEPHROTIC SYNDROME-ASSOCIATED WITH N-HYDROXYUREAS, INHIBITORS OF 5-LIPOXYGENASE, Archives of toxicology, 69(7), 1995, pp. 480-490
Authors:
GOODWIN DA
LALLY KP
CLARK RH
NULL DM
Citation: Da. Goodwin et al., FACTORS ASSOCIATED WITH THE DEVELOPMENT OF INTRACRANIAL HEMORRHAGE INPATIENTS TREATED WITH EXTRACORPOREAL MEMBRANE-OXYGENATION, Pediatric surgery international, 10(4), 1995, pp. 229-232
Authors:
GOODWIN DA
Citation: Da. Goodwin, TUMOR PRETARGETING - ALMOST THE BOTTOM LINE, The Journal of nuclear medicine, 36(5), 1995, pp. 876-879
Authors:
GOODWIN DA
RANSONE CM
DIAMANTI CI
MCTIGUE M
Citation: Da. Goodwin et al., RAPID SYNTHESIS AND QUALITY-CONTROL OF GA-68-LABELED CHELATES FOR CLINICAL USE, Nuclear medicine and biology, 21(6), 1994, pp. 897-899
Authors:
MORO MA
DARLEYUSMAR VM
GOODWIN DA
READ NG
ZAMORAPINO R
FEELISCH M
RADOMSKI MW
MONCADA S
Citation: Ma. Moro et al., PARADOXICAL FATE AND BIOLOGICAL ACTION OF PEROXYNITRITE ON HUMAN PLATELETS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(14), 1994, pp. 6702-6706
Authors:
WATANABE N
GOODWIN DA
MEARES CF
MCTIGUE M
CHAOVAPONG W
RANSONE CM
RENN O
Citation: N. Watanabe et al., IMMUNOGENICITY IN RABBITS AND MICE OF AN ANTIBODY-CHELATE CONJUGATE -COMPARISON OF (S) AND (R) MACROCYCLIC ENANTIOMERS AND AN ACYCLIC CHELATING AGENT, Cancer research, 54(4), 1994, pp. 1049-1054
Authors:
GOODWIN DA
MEARES CF
WATANABE N
MCTIGUE M
CHAOVAPONG W
RANSONE CM
RENN O
GREINER DP
KUKIS DL
KRONENBERGER SI
Citation: Da. Goodwin et al., PHARMACOKINETICS OF PRETARGETED MONOCLONAL-ANTIBODY 2D12.5 AND Y-88 OBENZYL)-1,4,7,10-TETRAAZACYCLODODECANETETRAACETIC ACID (DOTA) IN BALB C MICE WITH KHJJ MOUSE ADENOCARCINOMA - A MODEL FOR Y-90 RADIOIMMUNOTHERAPY/, Cancer research, 54(22), 1994, pp. 5937-5946
Authors:
GOODWIN DA
LANG EV
ATWOOD JE
DALMAN RL
RANSONE CM
DIAMANTI CI
MCTIGUE M
Citation: Da. Goodwin et al., VIABILITY AND BIODISTRIBUTION OF GA-68 MPO-LABELED HUMAN PLATELETS, Nuclear medicine communications, 14(11), 1993, pp. 1023-1029
Authors:
GOODWIN DA
LALLY KP
NULL DM
Citation: Da. Goodwin et al., EXTRACORPOREAL MEMBRANE-OXYGENATION SUPPORT FOR CARDIAC DYSFUNCTION FROM TRICYCLIC ANTIDEPRESSANT OVERDOSE, Critical care medicine, 21(4), 1993, pp. 625-627
Risultati:
1-15
|